BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6527103)

  • 1. Polyclonal and monoclonal antibodies as reagents in biochemical and in clinical-chemical analysis.
    Falkenberg FW; Pierard D; Mai U; Kantwerk G
    J Clin Chem Clin Biochem; 1984 Dec; 22(12):867-82. PubMed ID: 6527103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal hybridoma antibodies in human melanoma: current status.
    Burk MW
    Int Adv Surg Oncol; 1984; 7():241-70. PubMed ID: 6205999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
    Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
    Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New directions for the use of monoclonal antibodies in leukemia diagnosis and therapy].
    Ueda R; Ota K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1798-810. PubMed ID: 3010883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Novel mutation-specific monoclonal E-cadherin antibodies make possible allele differentiation at the protein level in tumors].
    Becker I; Becker KF; Kremmer E; Eulitz M; Handschuh G; Höfler H
    Verh Dtsch Ges Pathol; 1999; 83():233-9. PubMed ID: 10714216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibodies to rat sarcomata. I. Immunization procedures and source of lymphoid cells for hybridoma production.
    North SM; Styles JM; Hobbs SM; Dean CJ
    Immunology; 1982 Nov; 47(3):397-405. PubMed ID: 7129525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of leukemia with monoclonal antibodies].
    Majdic O; Bettelheim P; Liszka K; Lutz D
    Wien Klin Wochenschr; 1982 Aug; 94(15):387-97. PubMed ID: 7147979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obtention of rat monoclonal antibodies reactive with human leukaemic lymphoblasts.
    Lebacq AM; Bazin H
    Bull Cancer; 1983; 70(2):93-5. PubMed ID: 6575843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surface antigens defined by monoclonal antibodies as tumor markers in human leukemia.
    Knapp W; Majdic O; Bettelheim P; Liszka K; Lutz D
    Cancer Detect Prev; 1983; 6(1-2):281-6. PubMed ID: 6883386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new murine cell surface differentiation antigen (Leugp90) defined by a rat monoclonal antibody: cellular distribution and biochemical characterization.
    Moldenhauer G; Haustein D; Hüppe T; Wagner A; Hartmann KU
    J Immunol; 1982 Jun; 128(6):2664-9. PubMed ID: 6978911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment and characterization of monoclonal and polyclonal antibodies against human intestinal fatty acid-binding protein (I-FABP) using synthetic regional peptides and recombinant I-FABP.
    Kajiura S; Yashiki T; Funaoka H; Ohkaru Y; Nishikura K; Kanda T; Ajioka Y; Igarashi M; Hatakeyama K; Fujii H
    J Immunoassay Immunochem; 2008; 29(1):19-41. PubMed ID: 18080878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific inhibition of HLA class I and II antibodies by soluble antigens--a method for the identification of antibody specificity in sera from alloimmunized individuals.
    Sumitran-Karuppan S; Möller E
    Transplantation; 1994 Sep; 58(6):713-9. PubMed ID: 7940692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monoclonal antibodies in pharmacology].
    Uteshev BS
    Farmakol Toksikol; 1986; 49(2):5-10. PubMed ID: 3011494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental aspects of immunologically characterized proteins.
    Falkenberg FW; Gantenberg W; Jürgenliemk I; Mayer M; Pierard D; Riffelmann HD; Behrendt B; Waks T
    Clin Biochem; 1983 Feb; 16(1):10-6. PubMed ID: 6861333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies as catalysts and templates for organic chemical reactions.
    Green BS
    Adv Biotechnol Processes; 1989; 11():359-93. PubMed ID: 2644946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of radioligand antibodies in the treatment of malignancy.
    Maners AW; Sanders MM; Pappas AA
    Ann Clin Lab Sci; 1988; 18(1):53-7. PubMed ID: 3281561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal antibodies produced by human-human hybridomas].
    Chida J
    Gan To Kagaku Ryoho; 1984 Jan; 11(1):157-64. PubMed ID: 6607711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.